Heart BMJ

FEBRUARY 23, 2024

Objective The heterogeneous pathophysiology of the diverse heart failure with preserved ejection fraction (HFpEF) phenotypes needs to be examined. We aim to assess differences in the biomarkers among the phenotypes of HFpEF and investigate its multifactorial pathophysiology.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Biomarkers Hypertension 40

Journal of the American Heart Association

FEBRUARY 14, 2024

Pathological increases in renal sympathetic nerve activity contribute to the pathogenesis of heart failure with preserved ejection fraction (HFpEF).We In addition, renal injury, oxidative stress, inflammation, and profibrotic biomarkers were evaluated to determine pathways associated with RDN.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Blood Pressure Obesity 40

European Journal of Heart Failure

NOVEMBER 29, 2023

Methods Between 1 November 2018 and 31 December 2020, 10 162 patients with chronic or acute/worsening HF with reduced, mildly reduced, or preserved ejection fraction were enrolled from 220 centres in 41 European or ESC affiliated countries.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Quality of Life Biomarkers 75

Circulation: Heart Failure

SEPTEMBER 12, 2023

BACKGROUND:Obesity and adiposity are associated with an increased risk of heart failure with preserved ejection fraction (HFpEF); yet, specific underlying mechanisms remain unclear. Fasting blood samples collected at the time of the cardiopulmonary exercise test were used to assay obesity-related biomarkers. for all).

Biomarkers 40

Biomarkers Obesity Exercise Preserved Ejection Fraction 40

Journal of the American Heart Association

JANUARY 16, 2025

Patients with reduced left ventricular ejection fraction had higher PKM2 concentrations than those with preserved ejection fraction (18.34.5 These findings suggest that PKM2 is a potential biomarker for HF diagnosis and prognosis, warranting consideration for serial patient assessment. versus 7.82.3

Cardiac Function 45

Cardiac Function Heart Failure Biomarkers Preserved Ejection Fraction 45

Open Heart

MARCH 8, 2024

Methods This proof-of-concept study used four-dimensional (4D) flow cardiovascular MR (4D flow CMR) data of five healthy controls, five patients with heart failure with preserved ejection fraction and five patients with aortic stenosis (AS). Visual assessment of flow vectors was used to assess helicity and vorticity.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Aortic Biomarkers Heart Failure 52

Circulation: Heart Failure

MARCH 1, 2024

BACKGROUND:Older adults have markedly increased risks of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). Identifying novel biomarkers can help in understanding HF pathogenesis and improve at-risk population identification. Circulation: Heart Failure, Ahead of Print.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Risk Factors Atherosclerosis 40

European Journal of Heart Failure

MARCH 4, 2024

CI, confidence interval; CV, cardiovascular; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HHF, hospitalization for heart failure. Aim Vascular congestion may lead to an increase of carbohydrate antigen 125 (CA-125).

Heart Failure 40

Heart Failure Preserved Ejection Fraction Hospital Biomarkers 40

European Journal of Heart Failure

FEBRUARY 4, 2024

We measured 92 biomarkers using a proximity extension assay and assessed cardiac structure and function in all participants using echocardiography. We used multi-block projection to latent structure analysis to integrate clinical, echocardiographic, and biomarker variables.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Biomarkers Diabetes 40

Frontiers in Cardiovascular Medicine

MARCH 9, 2025

BackgroundHeart failure with preserved ejection fraction (HFpEF) is characterized by normal ejection fraction and diastolic dysfunction. A strong positive correlation was also observed between Hcy levels and New York Heart Association (NYHA) classification (r=0.824, p<0.001).ConclusionsThe

Preserved Ejection Fraction 52

Preserved Ejection Fraction Cardiac Function Heart Failure Bicuspid/Mitral 52

Open Heart

JANUARY 19, 2025

The association between GDF15 and clinical factors and its prognostic value in elderly multimorbid patients with heart failure with preserved ejection fraction (HFpEF) have not been well unknown. A predefined subcohort of 212 patients underwent multi-biomarker testing.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Biomarkers 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

He emphasized the evolving landscape of biomarker utility in enhancing the accuracy of HF prediction and the need for targeted interventions based on these biomarkers. He emphasized the evolving landscape of biomarker utility in enhancing the accuracy of HF prediction and the need for targeted interventions based on these biomarkers.

CME 103

CME Obesity Heart Failure Biomarkers 103

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

BackgroundHeart failure with preserved ejection fraction (HFpEF) is a common and heterogeneous syndrome with high mortality and morbidity.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Risk Factors Biomarkers Hospital 52

Frontiers in Cardiovascular Medicine

NOVEMBER 10, 2024

BackgroundHeart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) often coincide. There was no significant improvement of heart failure-related symptoms, echocardiographic parameters and cardiac biomarkers levels. Forty-two were female. ml/m2 vs. 25.8 ml/m2, g/m2 vs. 83.0 g/m2, P < 0.001).ConclusionWomen

Preserved Ejection Fraction 52

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 52